Skip to main content

SIR 2023 Main banner

Tweets by SIR 2023

Interventional Oncology

Session: Evolution in Management of Neuroendocrine Liver Metastases

NET gene mutations as prognostic biomarkers for response to TAE and TARE

Tuesday, March 7, 2023

9:22 AM – 9:35 AM

Location: Phoenix Convention Center, 222AB

Speaker(s)

EZ

Etay Ziv, MD PhD

Associate Attending
Memorial Sloan Kettering Cancer Center

Disclosure(s): Ethicon J&J: Research Grant Recipient (Ongoing); Novartis Pharmaceuticals Corporation: Research Grant Recipient (Ongoing)

Disclosure(s):

Etay Ziv, MD PhD: Ethicon J&J: Research Grant Recipient (Ongoing); Novartis Pharmaceuticals Corporation: Research Grant Recipient (Ongoing)